Pharmaceutical

Jazz and AbCellera sign deal for T-cell engagers in sol...

The collaboration involves up to $56m in upfront payments to AbCellera for the f...

USFDA and EUDRA dashboards offer lessons for strengthen...

Milind Sathe analyses how public regulatory dashboards can support pharmaceutic...

We’re building for global markets, not just domestic scale

As the next-generation leader of the company, Nupur Shah, CEO of Cyano Pharma is...

Lupin launches Azilsartan Medoxomil tablets in the Unit...

Company receives US FDA approval and secures 180-day generic drug exclusivity fo...

AviadoBio broadens vMiX gene silencing licence with Kin...

The agreement broadens AviadoBio’s existing rights, which were previously limite...

Altaris to acquire Simulations Plus in $375m all-cash deal

Under the deal, Simulations Plus shareholders will receive $18.50 per share, rep...

From fintech to aesthetic injectables: Lessons in navig...

Rishi Agrawal, CEO, TeamLease RegTech cautions that the recent CDSCO clarificati...

Karnataka holds 64th Vision Group on Biotechnology meet...

Meeting discusses biotechnology strategy, AI integration, biomanufacturing and f...

Glenmark launches Methylene Blue Injection USP in US

Generic injectable approved as bioequivalent to ProvayBlue Injection 50 mg/10 mL

ALK’s EURneffy secures MHRA approval for anaphylaxis tr...

This approval is said to be the first in the UK for a needle-free adrenaline tre...

Alkermes’ alixorexton secures FDA and EC orphan designa...

The FDA granted the status to alixorexton for idiopathic hypersomnia while the E...

ILAMED expands international presence with centres in K...

Institute to launch Cairo centre in September 2026 as part of its overseas exp...

Simcere and Stanford partner to develop IPF therapies

Under the deal, Simcere will provide funding for exploratory research on a first...

FDA clears MSD’s Keytruda combo plus Welireg for ccRCC ...

This approval covers patients with ccRCC who are at intermediate-high or high ri...

Novartis India launches Pluvicto for PSMA-positive meta...

Radioligand therapy approved for eligible patients with PSMA-positive prostate ...

Ipca Laboratories and Bhami’s Research Laboratory signs...

Agreement enables development and commercialisation of monoclonal antibody prod...